Valproate preparations for agitation in dementia

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Lonergan, Edmund ^a   Luxenberg, Jay ^a  

^a NONE   (United States)

Author keywords

Aged; Antimanic agents adverse effects; *therapeutic use ; Dementia *complications ; Humans; Psychomotor agitation *drug therapy; etiology ; Randomized controlled trials as topic; Valproic acid adverse effects; *therapeutic use

Indexed keywords

CHLORAL HYDRATE; LORAZEPAM; OXAZEPAM; VALPROATE SEMISODIUM; VALPROIC ACID;

ACCIDENT; AGGRESSION; AGITATION; ANXIETY DISORDER; ARTHROPATHY; ATAXIA; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CAREGIVER BURDEN; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DELIRIUM; DEMENTIA; DIARRHEA; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FALLING; FEVER; GASTROINTESTINAL DISEASE; HALLUCINATION; HUMAN; HYPONATREMIA; INFECTION; INJURY; INSOMNIA; MANIA; NAUSEA; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; REVIEW; SEDATION; SEIZURE; SEX DIFFERENCE; SIDE EFFECT; SKIN DISEASE; SMALL INTESTINE OBSTRUCTION; SOMNOLENCE; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT INFECTION; VOMITING; WEAKNESS; WEIGHT REDUCTION;

EID: 70049094586     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003945.pub3     Document Type: Review

References (48)

1. Herrmann N, Lanctot KL, Rothenberg LS, Eryavec G. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders 2007;23:116-119 (Pubitemid 46105702)
2. Porsteinsson AP, Tariot PN, Erb R, et al.Placebo controlled study of divalproex sodium for agitation in dementia. American Journal of Geriatr Psychiatry 2001;9(1):58-66. (Pubitemid 32062073)
3. * Sival RC, Haffmans PMJ, Jansen PA, Duursma SA. Sodium valproate in the treatment of aggressive behavior in patients with dementia - a randomised placebo controlled clinical trial. International Journal of Psychiatry 2002;17(6):579-585
4. * Tariot PN, Schneider LS, Mintzer JE, Cutler AJ, Cunningham MR, Thomas MS, et al.Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial. Curr Ther Rev 2001;62(1):51-67.
5. Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, et al.Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. American Geriatric Psychiatry 2005;13:942-949 (Pubitemid 46638660)
6. Forester B, VAnelli M, Hyde J, Perez R, Ahokpossi C, Scribney W, Adkison L. Report on an open label prospective study of divalproex sodium on the behavioral and psychological symptoms of dementia asmonotherapy and in combination with second generation antipsychotic medication. American Journal of Geriatric Pharmacotherapy 2007;5:209-217 (Pubitemid 350063664)
7. * Goldberg RJ. The use of adjunctive divalproex for neuroleptic unresponsive behavioral disturbances in nursing home residents with dementia. Ann Long-Term Care 1999;7:63-66
8. * Gupta S, O'Connell RO, Parekh A, et al.Efficacy of valproate for agitation and aggression in dementia: CAS reports. International Journal of Geriatric Psychopharmacology 1998;1:244-248
9. * Haas S, Vincent K, Holt J, Lippmann S. Divalproex: a possible treatment alternative for demented elderly aggressive patients. Ann Clin Psychiatry 1997;9:145-147
10. * Horne M, Lindley SE. Divalproex sodium in the treatment of aggressive behavior and disphoria in patients with organic brain syndromes. J Clin Psychiatry 1995;56:430-431
11. * Kasckow JW, McElroy SL, Cameron RL, Mahler LL, Fudala SJ. A pilot study on the use of divalproex sodium in the treatment of behavioral agitation in elderly patients with dementia: assessment with the BEHAVED-AD and CGI rating scales. Curr Ther Res 1997;58:351-354
12. Lott AD, McElroy SL, Keys MA. Valproate in the treatment of behavioral agitation in elderly patients with dementia. J Neuropsychiatry Clin Neurosci 1995;7:314-319
13. * Mazure CM, Druss BG, Cellar JS. Valproate treatment of older patients with organic mental syndromes and behavioral dyscontrol. J Am Geriatr Soc 1992;40:914-916
14. Mellow AM, Solano-Lopez C, Davis S. Sodiumvalproate in the treatment of behavioral disturbances in dementia. J Geriatr Psychiagtry Neurol 1993;6:205-209 (Pubitemid 23302139)
15. * Narayan M, Nelson JC. Treatment of dementia with behavioral disturbance ujsing divalproex or a combination of divalproex and neuroleptic. J Clin Psychiatry 1996;58:351-354
16. Narayan M, Nelson JC. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic. J Clin Psychiatry 1997;58:351-354 (Pubitemid 27375463)
17. Niedermier JA, Nasrallah HA. Clinical correlates of response to valproate in geriatric inpatients. Ann Clin Psychiatry 1998;10:165-168 (Pubitemid 29078269)
18. * Porsteinsson AP, Tariot PN, Erb R, Gaile S. An open trial of valproate for agitation in geriatric neuropsychiatric disorders. Am J Geriatr Psychiatry 1997;5:344-351
19. Sandborn WD, Bendfeldt F, Hamdy R. Valproic acid for physically aggressive behavior in geriatric patients. J Am Geriatr Soc 1995;3:239-242
20. * Sival RC, Haffman PMJ, Van Gent PP, van Nieuwkerk JF, Jansen PAF. The effects of sodium valproate on disturbed behavior in dementia. J Am Geriatr Soc 1994;42:906-907
21. * Takahashi M, Akagi M. Case report of sodium valproate treatment of aggression associated with Alzheimer's disease (in Japanese). No To Shinkei 1996;48:757-760
22. Tariot P, Porsteinsson AP, Jakimovich LJ, Kowalski N, Holt C. Open valproate treatment following a double-blind trial for agitation. Proceedings 8th International Conference of Alzheimer's Disease and Related Disorders, Stockholm, Sweden. 2002:26.
23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd Edition. Washington, DC: American Psychiatric Association, 1980.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd Edition. Washington, DC: American Psychiatric Publishing, 1987.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4. Washington, DC: American Psychiatric Publishing, 1994.
26. Billig N, Cohen-Mansfield J, Lipson S. Pharmaceutical treatment of agitation in a nursing home. Journal of the American Geriatrics Society 1991;39:1002-1005
27. Cohen-Mansfield J, Werner P, Marx MS. An observational study of agitation in agitated nursing home residents. International Psychogeriatrics 1989;1:153-165
28. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. Journal of Gerontology 1989;44:M77-84.
29. Colenda CC, Hamer RM. Antecedents and interventions for aggressive behavior of patients at a geropsychiatric state hospital. Hospital and Community Psychiatry 1991;42:287-292
30. COSTART:Coding Symbols Thesaurus for Adverse Reaction Terms. US Food and Drug Administration. 3. Rockville, MD: Center for Drugs and Biologics, Division of Drug and Biological Products Experience: US Food and Drug Adminstration, 1989.
31. Folstein MF, Folstein SE, McHugh PR. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12:189-198
32. Guy W. ECDEU Assessment Manual for Psychopharmacology. USA Department of Health, Education and Welfare Publication (ADM) 76-338. 2nd Edition. Washington, DC: US Government Printing Office, 1976:218-222
33. Herrmann N. Valproic acid treatment of agitation in dementia. Canadian Journal of Psychiatry 1998;43:69-72. (Pubitemid 28125132)
34. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL. A new clinical scale for the staging of dementia. British Journal of Psychiatry 1982;140:566-572
35. Lon AD, McElroy SL, Keys MA. Valproate in the treatment of behavioral agitation in elderly patients with dementia. Journal of Neuropsychiatry and Clinical Neurosurgery 1995;7:314-319
36. Lonergan ET, Luxenberg J, Colford J. Review: haloperidol does not reduce agitation in dementia. Evidence-based Medicine 2002;7:89.
37. McKhann G, Brackman D, Folstgein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944 (Pubitemid 14076461)
38. Mulrow CD, Oxman AD. Cochrane Collaboration Handbook. Oxford: Oxford Update Software, 1996 (Updated 1997).
39. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychology Reports 1962;10:799-812.
40. Overall J, Gorham D. Introduction: The brief psychiatric rating scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacology Bulletin 1988;24:97-98
41. Patel V, Hope T. Aggressive behavior in elderly people with dementia: a review. International Journal of Geriatric Psychiatry 1993;8:457-472 (Pubitemid 23191644)
42. Schneider LS, Olin JT, Doody RS, et al.Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders 1997;11(Suppl 2):S22-S32.
43. Trimble MR, Thompson PJ. Sodium valproate and cognitive function. Epilepsia 1984;25 (Suppl):S60-S64.
44. Verstraten PFJ. The GIP: an observational ward behavior scale. Psychopharmacology Bulletin 1988;24:717-719
45. World Health Organisation. ICD-10. Tenth revision of the International Classification of Diseases. Mental and Behavioural disorders. Clinical descriptions and diagnostic guidelines. 10th Edition. Geneva: World Health Organisation, 1991.
46. Wistedt B, Rasmussen A, Pedersen L, et al.The development of an observer-scale formeasuring social dysfunction and aggression. Pharmaco Psychiatry 1990;23:249-252
47. Yudofsky SC, Silver JM, Jaqckson W, et al.The overt aggression scale for the objective rating of verbal and physical aggression. American Journal of Psychiatry 1986;143:35-39
48. Lonergan E, Luxenberg J. Valproate preparations for agitation in dementia. Cochrane Database of Systematic Reviews 2004.[Art. No.: CD003945. DOI: 10.1002/14651858.CD003945.pub3]